In orthopaedic innovation terms, compared to both younger and older patient cohorts, middle-aged patients have been left behind over the last generation.

These patients have only been offered surgical solutions that were never truly intended for them. Solutions that were either designed for younger patients – and the surgeon is hoping they’ll work in the middle-aged population or designed for older patients where when applied to the middle-aged population, often represent an overtreatment.

Founded by Professor Leif Ryd, Episurf Medical helps surgeons treat middle-aged patients and their aging, but not aged, joints.

We provide options to surgeons treating “gap-patients,” who are often at a point in life where they are stuck in between surgical procedures always intended for the younger athletic population on one end, and end-stage total knee replacement or foot and ankle fusion procedures on the other.

Knowing successful surgical outcomes begin well in advance of the operating room, we strive first to assist surgeons with their treatment selection process. By using advanced 3D imaging technology, we help surgeons first identify exactly where their patients are experiencing pain, and then design and manufacture customised implants and surgical instruments tailored perfectly to their anatomy.

Episurf Medical’s head office is located in Stockholm, with sales representation in the United States, Europe, and Asia. The share (EPIS B) is listed on Nasdaq Stockholm. On our website, you will be able to find plenty of information about our technology and you will have the opportunity to meet patients who have been treated with Episealer. Do not hesitate to get in touch with us, should you want to know more.